Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Major trial launched to explore GLP-1 benefit in dementia A large-scale trial has been launched, with $100 million in backing, to explore whether lifestyle changes coupled with GLP-1 agonists or similar incretin therapies can reduce the risk of dementia
Sugary Beverages : These can lead to oxidative stress, reducing the efficacy of the antioxidant
Ngo-Hamilton says they may yield the strongest side effects
Patients should report any new or worsening symptoms to their healthcare provider promptly, including gastrointestinal issues or allergic reactions
US$ 28.12
US$ 29.81
US$ 24.17
